Back to results
US 11,130,741 B2Granted
Anti-infective heterocyclic compounds and uses thereof
AssigneeBioimics AB
InventorsLeif Kirsebom, Ram Shankar Upadhayaya, Raghava Reddy Kethiri, Anders Virtanen
Life of this patent
Estimating the term…
Abstract
The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.
Claims20
A compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein
- A is S;
- X1 is selected from CH and N;
- each of X2, X3, X4 and X5 is CH;
- R1 is selected from the group consisting of
- —H,
- —C1-6 alkyl,
- —C1-6 alkyl-amino wherein the amino group is optionally substituted with one or two C1-6acyl or C1-6alkyl groups,
- and
- —C1-6 alkyl-heterocyclyl wherein the heterocyclyl group is a 5- or 6-membered aliphatic or aromatic heterocycle, optionally benzo-fused, and is optionally substituted with one or more R6 groups;
- R2 is selected from the group consisting of —N(R5)2, —NHR5, —N(R5)C(O)R5, and —N(R5)C(S)N(R5)2;
- R3 is selected from —CF3, —CN, —Cl, —C1-6 alkyl, —C3-6 cycloalkyl, —C(O)NH2, —C(O)NH—C1-6 alkyl, —NH-heterocyclyl, -phenyl, and -heterocyclyl, wherein the heterocyclyl group is a 5- or 6-membered aliphatic or aromatic optionally benzo-fused heterocycle, and wherein R3 is optionally substituted with one of more R6 groups;
- each of R4 and R8 is selected from H, —CN, -halo, —CF3, —C1-6 alkoxy, —CO2—C1-6 alkyl, —NO2, —C1-6 alkyl-NH2, -heterocyclyl, and —CONHm[(CH2)nNH2]2-m, wherein the heterocyclyl group is a 5- or 6-membered aliphatic or aromatic optionally benzo-fused heterocycle;
- each instance of R5 is independently selected from the group consisting of
- —H,
- —C1-6 alkyl optionally substituted with one or more R6 groups,
- —C2-6 alkenyl optionally substituted with one or more R6 groups,
- —C0-3 alkyl-C3-6 cycloalkyl-C0-3 alkyl optionally substituted with one or more R6 groups,
- -phenyl optionally substituted with one or more R6 groups,
- —C═C-Ph optionally substituted with one or more R6 groups,
- and
- —C0-3 alkyl-heterocyclyl-C0-3 alkyl optionally substituted with one or more R6 groups, wherein the heterocyclyl group is a 5-, 6- or 7-membered aliphatic or aromatic optionally benzo-fused heterocycle;
- each instance of R6 is independently selected from the group consisting of -halo, —CN, —C1-6 alkyl, —OH, —C1-6 alkoxy, —C1-6 alkyl-NH2, —NHm[(CH2)nNH2]2-m, —NH2, —NH—C1-6 alkyl, and —N—C1-6dialkyl;
- n and m are integers, wherein each instance of n is independently chosen from 2 or 3, and each instance of m is independently chosen from 0 or 1.
22 more elements
A compound selected from the group consisting of
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.